Oncology Drugs

694 FDA-approved drugs

Recent Approvals

adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negativ...

ARVINAS OPERATIONS

LIFYORLI (COPACKAGED)

LIFYORLI is indicated in combination with nab-paclitaxel for the treatment of adults with platinum-r...

PEGZILARGINASE-NBLN

hyperargininemia in adult and pediatric patients 2 years of age and older with Arginase 1 Deficiency...

IMMEDICA PHARMA AB

INDICATIONS AND USAGE Fluorouracil Cream is recommended for the topical treatment of multiple actini...

patients with: Relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, in patien...

refractory testicular cancer in adult patients...

LEUCOVORIN CALCIUM

pernicious anemia and megaloblastic anemia secondary to lack of vitamin B 12 , because of the risk o...

FILGRASTIM-LAHA

ACCORD BIOPHARMA INC.

adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where...

AMNEAL PHARMS LLC

postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporot...

AMNEAL PHARMS LLC

RYBREVANT FASPRO

AMIVANTAMAB AND HYALURONIDASE-LPUJ

adult patients with locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858...

Johnson & Johnson

PEGFILGRASTIM-UNNE

the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation...

NILOTINIB HYDROCHLORIDE DIHYDRATE

NILOTINIB HYDROCHLORIDE DIHYDRATE

HETERO LABS LTD V

adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) w...

PERTUZUMAB-DPZB

SHANGHAI HENLIUS BIOTECH

adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible nucleopho...

patients with: Brain tumors, primary and metastatic, following appropriate surgical and/or radiother...

BELANTAMAB MAFODOTIN-BLMF

BLENREP is indicated in combination with bortezomib and dexamethasone for the treatment of adult pat...

Showing 20 of 694 drugs

Top Companies

Novartis 33 Pfizer 32 Teva 25 Bristol-Myers Squibb 25 Roche 21 Sanofi 15 Johnson & Johnson 14 Fresenius Kabi 14 Hikma 12 Eli Lilly 11

Drug Classes

Kinase Inhibitor 43

Alkylating Drug 18

RANK Ligand Inhibitor 17

Leukocyte Growth Factor 17

Nucleoside Metabolic Inhibitor 15

Programmed Death Receptor-1 Blocking Antibody 9

HER2/neu Receptor Antagonist 8

Endoglycosidase 6

Vascular Endothelial Growth Factor Inhibitor 6

Retinoid 6

Quick Stats

Total Drugs: 694
Companies: 274
Drug Classes: 70
Latest Approval: 2026-05-01